After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Abstract: This innovative practice full paper describes the exploration of the transformative potential of Generative Artificial Intelligence (AI) and Large Language Models (LLMs) in Python ...